Join
Live feed
·
PRReleasevia Quantisnow
Arvinas Inc. logo
Pfizer Inc. logo

Arvinas to Present Data from the Vepdegestrant Clinical Development Program at the 2025 European Society for Medical Oncology (ESMO) Congress

ByQuantisnow·Wall Street's wire, on your screen.
ARVN· Arvinas Inc.PFE· Pfizer Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARVN (Arvinas Inc.), PFE (Pfizer Inc.) and more on Quantisnow.